相关实验视频
Updated: Jan 16, 2026

07:54
Cholesterol Efflux Assay
Published on: March 6, 2012
30.6K
胆固醇排泄能力如何被用作动脉样硬化心血管疾病的风险因素?
1Department of Clinical Laboratory Technology, Faculty of Medical Science, Juntendo University, Urayasu, Japan.
Expert review of cardiovascular therapy
|October 1, 2025
概括
胆固醇外流容量 (CEC),衡量高密度脂蛋白胆固醇 (HDL-C) 功能,预测心血管疾病风险. 然而,增加CEC尚未被证明可以减少事件,因此需要研究HDL修饰途径.
科学领域:
- 心血管研究研究心血管研究
- 脂质代谢 脂质代谢是什么
- 生物标志物发现发现
背景情况:
- 高密度脂蛋白胆固醇 (HDL-C) 传统上是"好胆固醇",但提高水平并不能保证心血管事件减少.
- 焦点已经从HDL-C数量转移到它的功能,特别是胆固醇排泄能力 (CEC).
研究的目的:
- 审查关于CEC作为HDL功能标记物的证据,以预测动脉样硬化心血管疾病 (ASCVD).
- 探索影响CEC的因素及其测量的挑战.
- 确定新的生物标志物和治疗方法的未来研究方向.
主要方法:
- 来自PubMed和Web of Science (2011-2024) 的研究的系统审查.
- 对CEC和ASCVD的队列和病例控制研究的分析.
- 包括生活方式,遗传学,氧化应激和方法因素的数据.
主要成果:
- CEC 一贯预测ASCVD超出传统的脂质参数.
- 由于检测方法,治疗和高血糖重塑,CEC结果存在变化.
- 饮酒和遗传多态 (例如,ALDH2) 等生活方式因素会影响CEC.
结论:
- CEC是一个有前途的替代标记物,但不是减少ASCVD事件的已被证明的治疗标.
- 未来的研究应该针对HDL修饰分子 (例如,FABP5,ORM1) 寻找新的生物标志物和疗法.
- 需要一种更精确的方法来评估HDL-C水平以外的残留心血管风险.
相关概念视频
Cholesterol: Significance and Regulation
1.2K
Although not a source of energy, cholesterol plays a significant role as a foundational structure for bile salts, steroid hormones, and vitamin D, as well as being a crucial component of plasma membranes. Approximately 15% of blood cholesterol is derived from our diet, with the remainder synthesized from acetyl CoA by the liver and intestines. Cholesterol is eliminated from the body through its conversion into bile salts, which are eventually discarded in the feces.
Considering cholesterol and...
Considering cholesterol and...
1.2K
Atherosclerosis I: Introduction
923
Atherosclerosis is a progressive disorder characterized by the buildup of plaques on the arterial inner wall, causing them to narrow and harden over time. These plaques comprise lipids, calcium, blood components, carbohydrates, and fibrous tissue. The process primarily affects the intima of large and medium-sized arteries, reducing blood flow in any artery.Etiology and risk factorsThe cause of atherosclerosis is multifactorial, involving a complex interplay among endothelial injury, lipid...
923
Lipids: Dietary Sources and Requirements
1.8K
Lipids are an essential component of a balanced human diet. Triglycerides, which make up the majority of dietary lipids, are found in both saturated fats—commonly present in meat, dairy products, and certain tropical plants like coconut, and hydrogenated oils such as margarine and baking shortenings (trans fats)—and unsaturated fats, which are abundant in seeds, nuts, olive oil, and most vegetable oils. The main sources of cholesterol include egg yolks, various meats and organ...
1.8K
Atherosclerosis III: Management
321
Management of atherosclerosis involves an integrated strategy encompassing pharmacological treatment, surgical interventions, lifestyle changes, and nutrition therapy to address the multifactorial nature of the disease.Pharmacological TherapyA cornerstone of atherosclerosis management is the use of pharmacological agents. Statins, such as atorvastatin, are pivotal in inhibiting HMG-CoA reductase, an enzyme that catalyzes an initial step in cholesterol synthesis in the liver. This reduction in...
321
Lipid-Lowering Drugs: Statins and Miscellaneous Agents
1.3K
Hyperlipidemia, a medical condition often referred to as high cholesterol, is characterized by abnormally elevated levels of lipids in the bloodstream. When present in excess, these lipids, specifically cholesterol and triglycerides, can lead to serious health complications, often involving cardiovascular diseases. Illnesses like atherosclerosis, heart attacks, and pancreatitis have all been linked to untreated hyperlipidemia. This means controlling and regulating cholesterol and triglyceride...
1.3K
Coronary Artery Disease I: Introduction
882
Coronary Artery Disease (CAD): An Overview with Scientific InsightsCoronary Artery Disease (CAD), often referred to as C-A-D, is a prevalent blood vessel disorder classified under the broader category of atherosclerosis. Atherosclerosis is a pathological process characterized by the hardening and narrowing of arteries due to the accumulation of atherosclerotic plaques. These plaques are composed of cholesterol, fatty substances, inflammatory cells, calcium, and fibrin, reducing blood flow to...
882

